Weaker EZ PMI cancels China gains

Markets have slipped lower on the first day of the week, with the FTSE 100 down 30 points and back below 6800.

City of London
Source: Bloomberg

Weaker PMI figures from Europe have stymied any chance of an early bounce for European markets, and have cancelled out some of the good news from China, where the manufacturing PMI moved into expansion territory for the first time this year and touched its highest level since October. Miners have been in demand this morning thanks to the news, which has gone some way to leaving the FTSE as the relative outperformer; a change from previous weeks in which the heavy mining component weighed the index down. Oil prices and the situation in Iraq are still providing plenty of cause for concern, given the Iraqi army’s apparent inability to hold the line against the insurgents. 

The latest IPO has reverted to recent form, after TSB’s successful debut on Friday, as the AA sees its shares dip by 3%. Breakdown puns will be wheeled out as a result, but the underlying lesson is that investors are being very choosy about where they put their money, and AA doesn’t yet appear to provide compelling reasons for investment.

Attention now shifts to PMI data from the US, as indices look to build on their gains from last week. Perhaps some lift might be gained from the performance of Team USA at the World Cup, but it says much about the market that this is being suggested as a reason for optimism. Iraq should still dominate the news, especially as John Kerry arrives to shore up the beleaguered government in Baghdad. 

Ahead of the open, we expect the Dow Jones to start 17 points lower at 16,930.

Denne informasjonen er utarbeidet av IG, forretningsnavnet til IG Markets Limited. I tillegg til disclaimeren nedenfor, inneholder ikke denne siden oversikt over kurser, eller tilbud om, eller oppfordring til, en transaksjon i noe finansielt instrument. IG påtar seg intet ansvar for handlinger basert på disse kommentarene og for eventuelle konsekvenser som et resultat av dette. Ingen garanti gis for nøyaktigheten eller fullstendigheten av denne informasjonen. Personer som handler ut i fra denne informasjonen gjør det på egen risiko. Forskning gitt her tar ikke hensyn til spesifikke investeringsmål, finansiell situasjon og behov som angår den enkelte person som mottar dette. Denne informasjonen er ikke utarbeidet i samsvar med regelverket for investeringsanalyser, så derfor er denne informasjonen ansett å være markedsføringsmateriale. Selv om vi ikke er hindret i å handle i forkant av våre anbefalinger, ønsker vi ikke å dra nytte av dem før de blir levert til våre kunder. Se fullstendig disclaimer og kvartalsvis oppsummering.